TCTR20200710006已完成3 期
Effectiveness and Safety of Early Insulin Glargine Administration in Combination with Continuous Intravenous Insulin Infusion in the Management of Diabetic Ketoacidosis: A Randomized Controlled Trial
/A0 个研究点目标入组 60 人开始时间: 2020年7月10日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
Early combination of insulin glargine with IV insulin infusion led to a faster DKA resolution and a shorter LOS, without increasing hypoglycemia and hypokalemia.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 100 Years（—）
- 性别
- All
入选标准
- •Patients who age at least 18 years old and were diagnosed with DKA
排除标准
- •Glargine allergy
- •Euglycemic DKA
- •Hemodynamic instability (need vasopressor to maintain hemodynamic status) Pregnant or breastfeeding women
研究者
相似试验
已完成
4 期
Insulin Glargine in Type 2 Diabetic PatientsDiabetes Mellitus, Type 2NCT00347100Sanofi387
尚未招募
3 期
Effectiveness of Early Insulin Degludec Administration in Combination with Continuous Intravenous Insulin Infusion in the Management of Diabetic Ketoacidosis: A Prospective Multicenter Randomized Controlled TrialAdults (18 or more than 18 years old) with Diabetic ketoacidosisBasal insulinDegludecRebound hyperglycemiaHypokalemiaType 2 diabetes mellitusDiabetic ketoacidosisType 1 diabetes mellitusHypoglycemiaTCTR20230408002Pending80
已完成
不适用
Use of Insulin Glargine to Treat Diabetic KetoacidosisDiabetic KetoacidosisNCT00179127Vanderbilt University Medical Center75
终止
2 期
Early Administration of Insulin Glargine in Patients With Diabetic KetoacidosisDKANCT06007508HealthPartners Institute8
招募中
不适用
Effect of long acting insulin in addition to standard treatment in management of diabetic ketoacidosisCTRI/2022/06/043076Postgraduate Institute of Medical Education and Research PGIMER